Page last updated: 2024-08-16

resveratrol and cytarabine

resveratrol has been researched along with cytarabine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baruchello, R; Bonora, C; Buscemi, F; Grimaudo, S; Pizzirani, D; Roberti, M; Rondanin, R; Simoni, D; Tolomeo, M1
Bauer, W; Erker, T; Fritzer-Szekeres, M; Hoechtl, T; Horvath, Z; Illmer, C; Jaeger, W; Madlener, S; Saiko, P; Szekeres, T2
Erker, T; Fritzer-Szekeres, M; Grusch, M; Handler, N; Horvath, Z; Jaeger, W; Krupitza, G; Madlener, S; Murias, M; Saiko, P; Szekeres, T1
Bernhaus, A; Erker, T; Fritzer-Szekeres, M; Graser, G; Grusch, M; Handler, N; Horvath, Z; Jaeger, W; Jaschke, M; Krupitza, G; Lackner, A; Madlener, S; Ozsvar-Kozma, M; Saiko, P; Szekeres, T1
Capasso, M; Ciprandi, G; Della Volpe, A; Malafronte, L; Mansi, N; Varricchio, A; Varricchio, AM1
Cragg, GM; Pezzuto, JM1

Reviews

1 review(s) available for resveratrol and cytarabine

ArticleYear
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2016, Volume: 25 Suppl 2

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Products; Cancer Vaccines; Chemoprevention; Cytarabine; Dietary Supplements; Humans; Neoplasms; Phytochemicals; Resveratrol; Stilbenes

2016

Trials

1 trial(s) available for resveratrol and cytarabine

ArticleYear
Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience.
    Italian journal of pediatrics, 2014, Nov-23, Volume: 40

    Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Glucans; Child; Cytarabine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Life Change Events; Male; Recurrence; Respiratory Tract Infections; Resveratrol; Stilbenes; Treatment Outcome; Vasodilator Agents

2014

Other Studies

5 other study(ies) available for resveratrol and cytarabine

ArticleYear
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
    Journal of medicinal chemistry, 2003, Jul-31, Volume: 46, Issue:16

    Topics: Antineoplastic Agents; Apoptosis; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Isomerism; Resveratrol; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured

2003
Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Experimental hematology, 2005, Volume: 33, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Differentiation; Cytarabine; Deoxyribonucleotides; DNA; Drug Synergism; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Resveratrol; Ribavirin; Ribonucleotide Reductases; Stilbenes

2005
Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
    Experimental hematology, 2006, Volume: 34, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxyribonucleotides; Drug Evaluation, Preclinical; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; NF-kappa B; Pyrogallol; Resveratrol; Ribonucleotide Reductases; Ribonucleotides; Stilbenes; Tumor Necrosis Factor-alpha; Wine

2006
Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Nucleosides, nucleotides & nucleic acids, 2006, Volume: 25, Issue:9-11

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Free Radical Scavengers; Free Radicals; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Resveratrol; Ribavirin; Stilbenes

2006
N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
    International journal of oncology, 2007, Volume: 31, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cytarabine; Cytidine; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Resveratrol; Ribonucleotide Reductases; Stilbenes

2007